Vox Members got to read this story first. Support independent journalism and get exclusive access to stories like this by becoming a Vox Member today. It can feel disheartening — but that common ...

In the wake of Anthropic’s $1.5 billion copyright settlement, the AI industry is coming to terms with its training data problem. There are as many as 40 other pending cases that seek damages for ...

In a quest to bolster a long-running claim from President Trump concerning undocumented immigrants illegally voting, the Justice Department is seeking detailed voter roll data from over 30 states. By ...

Cloud backup makes it easier than ever to secure and access off-site data. We test and rank the top cloud backup services for businesses to help you decide the best way to safeguard your valuable ...

The funding covers more than half of the A.I. data centers that OpenAI plans to build in the U.S. over the next several years. By Cade Metz Reporting from San Francisco OpenAI has signed a deal with ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...

Atherosclerosis is the primary cause of cardiovascular disease, and the risk for atherosclerosis is inversely proportional to circulating levels of high-density lipoprotein (HDL) cholesterol. However, ...

Jordan Freiman is a news editor for CBSNews.com. He covers breaking news, trending stories, sports and crime. Jordan has previously worked at Spin and Death and Taxes.

The tech layoff wave is still kicking in 2025. Last year saw more than 150,000 job cuts across 549 companies, according to independent layoffs tracker Layoffs.fyi. So far this year, more than 22,000 ...

3:15pm: There’s no immediate timetable for Bichette’s return. Manager John Schneider tells the Jays beat that Bichette, who first felt discomfort in his shin and knee on Sunday, will rest for the ...

The FDA reinstated normal regulations on compounded GLP-1s after a temporary relaxation during a shortage, emphasizing safety concerns. Major pharmaceutical companies are blocking compounding of ...